Regeneron Pharmaceuticals, Inc. Company Profile

Aggregated data from the web about Regeneron Pharmaceuticals, Inc.

Company Name	Regeneron Pharmaceuticals, Inc.
Website	https://www.regeneron.com
Snippet	Regeneron Pharmaceuticals, Inc. and its affiliates, Regeneron Ireland Unlimited Company and Regeneron UK Limited (together, "Regeneron", "we", "us" or "our") use this data to make the Sites more user-friendly and efficient. We use Google Analytics cookie service to track and obtain reports on how visitors are using the Sites.
Type	Public
Founded	1988
Revenue	$7.86 billion (2019)[1]
Website	www.regeneron.com
Industry	Pharmaceuticals; Biotech
Traded as	NASDAQ: REGN, NASDAQ-100 component, S&P 500 component
Key people	Leonard Schleifer (CEO)George Yancopoulos (CSO)
Net income	$1.4 billion (2019)[2]
Area served	Global
Headquarters	Eastview/Tarrytown, New York, US (global headquarters)
Total assets	$5.6 billion (2019)[2]
Number of employees	8,100 (2019)[1]

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.